News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pulmatrix Presents Preclinical Data On iSPERSE Inhaled Antibiotics At The 2014 Respiratory Drug Delivery Conference


5/5/2014 9:56:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Pulmatrix today presented data at the 2014 Respiratory Drug Delivery Conference in Fajardo, Puerto Rico. The poster presentation includes development data on PUR0400, a preclinical drug candidate of fluoroquinilone Levofloxacin formulated in the company’s proprietary iSPERSE™ dry powder technology.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Pulmatrix
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES